WAYNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth…
Company Announcement Genmab A/S to hold Annual General Meeting on Wednesday March 12, 2025 COPENHAGEN, Denmark; February 13, 2025 –…
The Board of Directors of Vistin Pharma ASA (VISTN) will propose to distribute a cash dividend of total NOK 1.25…
LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”)…
VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse…
Brings over 30 years of life sciences industry experienceCo-led the McKinsey Global Life Sciences practice Bergen, Norway, February 12, 2025…
PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with…
Oslo, Norway, 13th of February 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and…
Gilde Healthcare announces successful sale of health-IT software company Performation to Enovation, part of Legrand Exit confirms Gilde's investment strategy…
Ad hoc announcement pursuant to Art. 53 LR AGAMREE® is the first product to receive an agreed federal price in…